Saturday, October 29, 2016 Cincinnati, Ohio

15th Annual Psychopharmacology Update: Psychiatric Pharmacotherapies:
Controversies, Evidence and Best Practices

Sessions are scheduled for 60 minutes, with the last 15 for Q&A
Agenda is subject to change. Please check back for updates.

Saturday, October 29, 2016
6:30 am – 7:30 am Registration and Breakfast
7:30 am – 8:30 am Breakfast Symposium
8:30 am – 8:40 am Welcome and Introduction
Henry A. Nasrallah, MD

8:40 am – 9:40 am Controversy I
Should Antidepressants Ever Be Used for Bipolar Depression?
Joseph F. Goldberg, MD

9:40 am – 10:40 am Controversy II
Is Lithium Preferable to an Anticonvulsant for Bipolar I Disorder?
Roger S. McIntyre, MD

10:40 am – 11:05 am Break

11:05 am – 12:05 pm Controversy III
Is Adjunctive Therapy Better than Switching for
Treatment-Resistant Depression?
Joseph F. Goldberg, MD

12:05 pm – 1:05 pm Controversy IV
Is adult ADHD a Variant of Bipolar Disorder or a Separate Disorder?
David Goodman, MD

1:05 pm – 2:30 pm Lunch Symposium (Non-CME)
Clinical Experts in Bipolar Depression
Diagnosis and Management: From Clinical Data to Clinical Practice
Faculty: Roger McIntyre, MD, FRCPC
Sponsored by: Sunovion Pharmaceuticals Inc.

2:30 pm – 2:45 pm Dessert Break/Exhibits

2:45 pm – 3:45pm Controversy V
Should Long-acting Injectable Antipsychotics Should Be Routinely Used for the First Episode of Schizophrenia?
Henry A. Nasrallah, MD

3:45 pm – 4:45 pm Controversy VI
Controversies in the Pharmacotherapy of Child and Adolescent Psychiatry
Melissa P. DelBello, MD

4:45 pm – 5:00 pm Break

5:00 pm – 6:00 pm Controversy VII
Why Use the Neurotoxic First-Generation Antipsychotics Given the Many
Neuroprotective Properties of the Second Generation Antipsychotics?
Henry A. Nasrallah, MD

6:00 pm – 6:30 pm Q&A with Faculty Panel